文献速递外周动脉疾病

GLASS分期系统在接受新发腹股沟下血运重建的慢性肢体威胁性缺血患者中的验证

Validation of the GLASS Staging Systems in Patients With Chronic Limb-Threatening Ischemia Undergoing De Novo Infrainguinal Revascularization.
PubMed 文献 · Ann Vasc Surg · 2021-11-12

该回顾性研究分析了2010至2018年间153例慢性肢体威胁性缺血患者190条患肢,评估GLASS分期与腹股沟下血运重建后保肢、创面愈合及总生存的关系。多因素分析显示仅WIfI分期和踝下病变是主要截肢和创面愈合不良的危险因素,GLASS分期与保肢或创面愈合无关,但为2年总生存的危险因素(P<0.01)。

要点

  • WIfI分期和踝下病变预测腹股沟下血运重建后的保肢和创面愈合。
  • GLASS分期与保肢或创面愈合无关。
  • GLASS分期是2年总生存的危险因素(P<0.01)。

核心结论

  • WIfI分期和踝下病变预测慢性肢体威胁性缺血患者腹股沟下血运重建后的保肢和创面愈合。
  • GLASS分期不影响保肢或创面愈合,但是总生存不良的预后因素。
  • GLASS分期可用于在预测预后时决定选择旁路手术还是腔内治疗。

研究设计与样本

  • 回顾性分析2010至2018年间因慢性肢体威胁性缺血接受腹股沟下血运重建的患者数据。
  • 153例患者190条患肢(Fontaine III和IV级)分析主要截肢和总生存。
  • 125例患者157条患肢(Fontaine IV级)分析创面愈合。

主要发现

  • WIfI分期1、2、3、4期患者分别为14例(7.4%)、44例(23.2%)、65例(34.2%)、67例(53.3%)。
  • GLASS分期I、II、III期患者分别为23例(12.1%)、48例(25.3%)、119例(62.6%)。
  • 190条患肢中,旁路手术132条(69.5%),腔内治疗39条(20.5%),杂交治疗19条(10.0%)。
  • 多因素分析显示仅WIfI分期和踝下病变是主要截肢和创面愈合不良的危险因素。
  • 多因素分析显示年龄、老年营养风险指数和GLASS分期是2年总生存的危险因素(P<0.01)。

临床怎么用

  • 作者认为GLASS分期可用于在预测预后时决定选择旁路手术还是腔内治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Global Limb Anatomic Staging System (GLASS) was proposed for evaluating the anatomic complexity of arterial disease in patients with chronic limb-threatening ischemia (CLTI). We aimed to examine the relationship between GLASS stage and treatment outcomes after infrainguinal revascularization in patients with CLTI. METHODS: We retrospectively analyzed data of patients undergoing infrainguinal revascularization for CLTI between 2010 and 2018 to examine whether GLASS stage affects the limb salvage, wound healing, and overall survival (OS). RESULTS: Throughout the study period, 153 CLTI patients and 190 limbs with Fontaine classification III and IV were analyzed for major amputation and OS, and 125 patients and 157 limbs of Fontaine classification IV were analyzed for wound healing. The number of patients with WIfI stage 1, 2, 3, and 4 was 14 (7.4%), 44 (23.2%), 65 (34.2%), and 67 (53.3%), respectively. The number of patients with GLASS stage I, II, and III was 23 (12.1%), 48 (25.3%), and 119 (62.6%), respectively. Among the 190 limbs, the number subject to bypass surgery, endovascular therapy, and hybrid therapy was 132 (69.5%), 39 (20.5%), and 19 (10.0%), respectively. A multivariate analysis showed that only WIfI stage and inframalleolar (IM) disease were risk factors for major amputation and impaired wound healing. There was no relationship between GLASS stage and limb salvage or wound healing. A multivariate analysis revealed that age, geriatric nutritional risk index and GLASS stage were risk factors for 2-year OS (P < 0.01). Patients with all risk factors had a poor prognosis (35.3% at 2 years). CONCLUSION: WIfI stage and IM disease predicted limb salvage and wound healing after infrainguinal revascularization in patients with CLTI. Although GLASS stage did not affect limb salvage or wound healing, it was a prognostic factor for poor OS. The GLASS staging could be useful for deciding between bypass surgery and endovascular therapy in prediction of prognosis.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Morisaki K, Matsubara Y, Yoshino S, et al. Validation of the GLASS Staging Systems in Patients With Chronic Limb-Threatening Ischemia Undergoing De Novo Infrainguinal Revascularization. Ann Vasc Surg. 2021. PMID: 34780947. doi:10.1016/j.avsg.2021.09.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。